The company said that recent study results show its Aventa Lymphoma test can provide actionable information that would typically be missed by FISH testing.

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced it will be presenting new data ...

Researchers at the University of California San Diego School of Medicine have developed a new approach for identifying ...

Researchers successfully developed a machine learning-based method for predicting symptom deterioration in patients with cancer.

In cancer care, every day that passes can cost a life. First Ascent Biomedical is racing against that clock. By testing a patient's live cancer cells outside the body, the company reveals how their ...

We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...